Company intelligence / Profile preview

Pasaca Capital

Pasadena, California, United States

Ownership: Private
Employees: ~70
Development stage: Other

Overview

Pasaca Capital is an evergreen private equity firm based in Pasadena, California, investing globally in sectors including medical devices, pharmaceuticals, TMT, industrial & automation, food ingredients, and other innovative technologies; it is an investor rather than a drug developer and has no therapeutic pipeline of its own.[1][2][3][5][7][8][9]

Industry: Investors

Partnerships

Sinopharm (China National Pharmaceutical Group) via Sino-Innovax Biotech joint venture with Innova Medical Group/CNBG for COVID-19 and other vaccines manufacturing and global distribution[2][4]

Beyond the preview

Go deeper on Pasaca Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pasaca Capital.

Explore the full profile